Erlotinib is an anti-cancer medication used to treat non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. Erlotinib is effective in targeting specific mutations in cancer cells. Common side effects may include rash and diarrhea, but these usually resolve over time. In summary, Erlotinib is crucial for managing specific types of cancer.
Erlotinib inhibits the tyrosine kinase activity of EGFR, preventing downstream signaling pathways that promote cancer cell proliferation.






